Sector Expert: Katherine Genis

Edison Investment Research

Subscribe to
Streetwise Reports

Companies Commented On



Recent Quotes

"Phase 3 study data will support approval of MESO's MPC-150-IM."

— Katherine Genis, Edison Investment Research (3/24/16)
more >

"MSB continues to make good pipeline progress."

— Katherine Genis, Edison Investment Research (1/25/16)
more >

"The first patient was transplanted in STEM's Phase 2 dry AMD trial."

— Katherine Genis, Edison Investment Research (9/1/15)
more >

"MSB's pipeline continues to mature steadily."

— Katherine Genis, Edison Investment Research (8/19/15)
more >

"A decision in Japan on MSB's MSC-100-IV could be a significant catalyst."

— Katherine Genis, Edison Investment Research (7/23/15)
more >

"We believe STEM's shares offer considerable value."

— Katherine Genis, Edison Investment Research (6/8/15)
more >

"MSB's late-stage product pipeline is burgeoning."

— Katherine Genis, Edison Investment Research (3/30/15)
more >

"We estimate dry AMD could be a $2B opportunity for STEM."

— Katherine Genis, Edison Investment Research (1/7/15)
more >



Due to permission requirements, not all quotes are shown.